94236-20-1

Basic information

• Product Name: Silane, [(2-bromophenyl)methoxy](1,1-dimethylethyl)dimethyl-
• CAS NO: 94236-20-1
• Molecular Formula: C13H21BrOSi
• Molecular Weight: 301.299
• Mol File: 94236-20-1.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Silane, [(2-bromophenyl)methoxy](1,1-dimethylethyl)dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Silane, [(2-bromophenyl)methoxy](1,1-dimethylethyl)dimethyl-(94236-20-1)
• EPA Substance Registry System: Silane, [(2-bromophenyl)methoxy](1,1-dimethylethyl)dimethyl-(94236-20-1)

Safety Data

• Hazardous Substances Data: 94236-20-1(Hazardous Substances Data)

Upstream product

• 18982-54-2 o-bromobenzyl alcohol 
• 18162-48-6 tert-butyldimethylsilyl chloride 

Downstream Products

• 22115-41-9 2-(bromomethyl)benzonitrile 
• 1391828-93-5 C₁₀H₁₂O₂ 
• 1394295-61-4 C₂₆H₃₀O₇ 
• 1394295-55-6 C₂₁H₃₂O₃Si 
• 1394295-45-4 C₃₀H₄₁FO₃Si 
• 1394295-39-6 C₂₇H₃₆O₃Si 
• 1394295-37-4 C₃₀H₄₂O₃Si 
• 1394295-32-9 C₂₅H₄₀O₃Si 
• 1187820-70-7 6-[2-[(tert-butyldimethylsilanyl)oxymethyl]phenyl]-2-chloroimidazo[1,2-a]pyridine 
• 1187820-72-9 [2-[2-(Furan-3-yl)imidazo[1,2-a]pyridin-6-yl]phenyl]methanol 
• 1187820-71-8 6-[2-[(tert-Butyldimethylsilanyl)oxymethyl]phenyl]-2-(furan-3-yl)imidazo[1,2-a]pyridine 
• 1173102-10-7 tert-butyldimethylsilyl 2-(methylselenyl)benzyl ether 
• 221543-24-4 2-(tert-butyldimethylsilyloxymethyl)phenylmagnesium bromide 
• 240122-06-9 5-[2-(tert-butyl)dimethylsilyloxymethyl-phenyl]-2-vinyl-furan 

Relevant articles and documents

Intramolecular nonbonded interactions between divalent selenium centers with donor and acceptor substituents

To investigate the intramolecular van der Waals interactions between two divalent selenium, centers in the solid state and in solution, we have prepared methyl 2-(methylselenyl)benzyl selenide (1), ethynyl 2-(methylselenyl)benzyl selenide (2), and 2-(meth

Macrocyclic MCL-1 inhibitors and methods of use

The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).

A mild and highly efficient method for the preparation of silyl ethers using Fe(HSO4)3/Et3N by chlorosilanes

Avery efficient and mild procedure for preparation of silyl ethers from benzylic, allylic, propargilic alcohols, phenols, naphtoles and some of phenolic drugs with trimethylsilylchloride (TMSCl), triethylsilylchloride (TESCl) and t-buthyldimethylsilyl chloride (TDSCl) ethers in the presence of Fe(HSO 4)3/Et3N in roomtemperature in excellent yields is reported. This procedure also allows the excellent selectivity for silylation of alcohols and phenols.